Rx Importation: Califf's Switch Means US FDA Commissioners No Longer Uniformly Opposed

24 Apr 2019

• By Michael Cipriano

In JAMA editorial, former FDA chief supports drug importation under narrow circumstances as a way to reduce drug prices, marking a shift from his previous stance on the issue and that of other past agency heads. Essay, co-authored by former CMS Acting Administrator Andy Slavitt, calls importation "a workaround born of desperation."

pills #259294352 — Former FDA Commissioner Robert Califf Expresses Support For Drug Importation.

US Food and Drug Administration commissioners have almost universally opposed importing drugs from foreign countries as a mechanism to reduce drug prices, but Robert Califf now looks to have bucked that trend. At least somewhat.

Writing in an 23 April Journal of the American Medical Association editorial with former Centers for Medicare and Medicaid Services...